EBM Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Choi, H.
Right arrow Articles by Kim, M.-S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Choi, H.
Right arrow Articles by Kim, M.-S.
Experimental Biology and Medicine 231:463-472 (2006)
© 2006 Society for Experimental Biology and Medicine


ORIGINAL RESEARCH ARTICLE

In Vivo Hyperoxic Preconditioning Prevents Myocardial Infarction by Expressing Bcl-2

Hong Choi*,1, Sang-Hyun Kim{dagger},1, Yang-Sook Chun{ddagger}, Young-Suk Cho*, Jong-Wan Park* and Myung-Suk Kim*,2

* Department of Pharmacology, {dagger} Department of Internal Medicine, and {ddagger} Department of Physiology, Seoul National University College of Medicine and Heart Research Institute SNUMRC, 28 Yongon-dong, Chongno-gu, Seoul 110-799, Korea

To whom requests for reprints should be addressed at 2 Department of Pharmacology, Seoul National University College of Medicine, 28 Yongon-dong, Chongno-gu, Seoul 110-799, Korea. E-mail: kimmsu{at}snu.ac.kr

Preconditioning with oxidative stress has been demonstrated in vitro to stimulate the cellular adaptation to subsequent severe oxidative stress. However, it is uncertain whether this preconditioning works in vivo. In the present study, we examined in vivo the beneficial effect of oxidative preconditioning. After rats were pretreated with whole-body hyperoxygenation (100% O2 at 3 atmosphere for 20 mins, four cycles with 20-min intermission), isolated hearts were subjected to 45-min ischemia followed by 90-min reperfusion. This hyperoxic preconditioning significantly reduced infarct size, cytochrome-c release, DNA fragmentation, and terminal deoxynucleotidyl transferase-mediated dUTD nick-end labeling-positive cell frequency in the left ventricle, biphasically with an early (30-min) and a delayed (48-hr) effect after the hyperoxygenation. Mechanistically, the NF-{kappa}B activity and Bcl-2 expression were enhanced in the hearts, and a NF-{kappa}B inhibitor, pyrrolidine dithiocarbamate, abolished the Bcl-2 induction as well as the infarct-limiting effect. An antioxidant, N-acetylcysteine, and protein kinase C (PKC) inhibitors chelerythrine and Gö 6983 also blocked the preconditioning effects. These results indicate that hyperoxia induces myocardial tolerance against ischemia-reperfusion injury in association with Bcl-2 induction by NF-{kappa}B activation through reactive oxygen species and PKC-dependent signaling pathway.

Key Words: hyperoxia • preconditioning • reperfusion injury • heart • NF-{kappa}B • Bcl-2




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
X. Lu, H. Liu, L. Wang, and S. Schaefer
Activation of NF-{kappa}B is a critical element in the antiapoptotic effect of anesthetic preconditioning
Am J Physiol Heart Circ Physiol, May 1, 2009; 296(5): H1296 - H1304.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
C. Han, L. Lin, W. Zhang, L. Zhang, S. Lv, Q. Sun, H. Tao, J. H. Zhang, and X. Sun
Hyperbaric Oxygen Preconditioning Alleviates Myocardial Ischemic Injury in Rats
Experimental Biology and Medicine, November 1, 2008; 233(11): 1448 - 1453.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
M.-L. Kaljusto, K.-O. Stenslokken, T. Mori, A. Panchenko, M.-L. Frantzen, G. Valen, and J. Vaage
Preconditioning effects of steroids and hyperoxia on cardiac ischemia-reperfusion injury and vascular reactivity
Eur. J. Cardiothorac. Surg., March 1, 2008; 33(3): 355 - 363.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the Society for Experimental Biology and Medicine.